Table 3. Attainment of recommended cholesterol targets in each subgroup.

	Number of patients in each subgroup	LDL-C attainment rate (%)	P value for difference among subgroup
Gender			P<0.0001
Male	6860	28.5
Female	5180	22.2
BMI (Kg/m2)			P<0.0001
<18.5	300	38.3
18.5–24.9	6252	28.1
25.0–29.9	3676	26.0
≥30.0	533	17.4
Age group (years)			P<0.0001
20–29	69	30.4
30–39	431	24.6
40–49	1505	23.8
50–59	3176	23.3
60–69	3386	24.3
70–79	2518	29.7
≥80	955	32.5
Risk stratification			P<0.0001
Low	2408	38.1
Moderate	2528	29.7
High	5177	19.9
Very high	1926	21.1
Centers			P<0.0001
Tertiary	8668	28.0
Non-tertiary	3372	20.1
Statin treatment group			P<0.0001
Simvastatin	1376	36.2
Atorvastatin	2011	34.9
Rosuvastatin	717	51.1
Others	628	40.0

BMI: body mass index.